Singapore markets open in 7 hours 29 minutes

Onconetix, Inc. (ONCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1496-0.0038 (-2.48%)
As of 01:16PM EDT. Market open.

Onconetix, Inc.

201 East Fifth Street
Suite 1900
Cincinnati, OH 45202
United States
513 620 4101
https://onconetix.gcs-web.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees12

Key executives

NameTitlePayExercisedYear born
Dr. Ralph Schiess Ph.D.Interim CEO & Chief Science OfficerN/AN/A1979
Ms. Karina M. FedaszInterim Chief Financial OfficerN/AN/A1973
Dr. Brian Price Ph.D.Head of Technology Strategy126.48kN/AN/A
Mr. Frank A. Jaeger M.A., M.B.A.Senior VP of Marketing & Business DevelopmentN/AN/A1970
Mr. Andrew D. Skibo Ph.D.Global Head of Biologics OperationsN/AN/AN/A
Mr. Theodore Scott YohoHead of Business DevelopmentN/AN/AN/A
Dr. Ali I. Fattom Ph.D.Head of Science & DiscoveryN/AN/AN/A
Dr. Jay Newmark M.B.A., M.D.Chief Medical OfficerN/AN/AN/A
Mr. Christian BruhlmannChief Strategy Officer & GM of EuropeN/AN/A1977
Dr. Donald L. Very Jr., Ph.D.Senior VP of Commercial Research & DevelopmentN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Corporate governance

Onconetix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.